Investment
Features
FeesSafety
Academy
More
Pluang+

Compare InMode Ltd (INMD) vs Mesoblast Limited (MESO) Price & Performance

InMode LtdTrade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

InMode Ltd vs Mesoblast Limited — how do they compare? InMode Ltd trades at $15.16 (market cap $872.08M), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Mesoblast Limited is far larger — about 2.5× InMode Ltd's market cap, and InMode Ltd is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.

INMDMESO
Market Cap
$872.08M$2.21B
Sector
TechnologyTechnology
52-Week High
$16.62$20.96
52-Week Low
$12.76$12.88
Enterprise Value
$375.42M$2.21B

Returns comparison

Trailing returns across standard periods

About InMode Ltd

InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.

Read more on INMD

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO